| 2YS | Name: | D-valyl-N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-L-leucinamide | Formula: | C18 H37 Cl N4 O3 | SMILES: | O=C(NC(CCCCN)C(O)CCl)C(NC(=O)C(N)C(C)C)CC(C)C | InChi: | InChI=1S/C18H37ClN4O3/c1-11(2)9-14(23-18(26)16(21)12(3)4)17(25)22-13(15(24)10-19)7-5-6-8-20/h11-16,24H,5-10,20-21H2,1-4H3,(H,22,25)(H,23,26)/t13-,14-,15+,16+/m0/s1 | Synonyms: | D-VAL-LEU-LYS-chloromethylketone | Definition date: | 2014-04-29 | Last modified: | 2024-09-27 | Release date: | 2014-09-03 | Identifier: | D-valyl-N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-L-leucinamide |
|
| OW9 | Name: | 1-(3-methylphenyl)carbonylpyrrolo[3,2-c]pyridine-3-carbonitrile | Formula: | C16 H11 N3 O | SMILES: | Cc1cccc(c1)C(=O)n2cc(C#N)c3cnccc23 | InChi: | InChI=1S/C16H11N3O/c1-11-3-2-4-12(7-11)16(20)19-10-13(8-17)14-9-18-6-5-15(14)19/h2-7,9-10H,1H3 | Definition date: | 2022-09-22 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | 1-(3-methylphenyl)carbonylpyrrolo[3,2-c]pyridine-3-carbonitrile |
|
| 2YT | Name: | L-phenylalanyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide | Formula: | C25 H35 Cl N6 O3 | SMILES: | ClCC(O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)Cc2ccccc2)CCCNC(=[N@H])N | InChi: | InChI=1S/C25H35ClN6O3/c26-16-22(33)20(12-7-13-30-25(28)29)31-24(35)21(15-18-10-5-2-6-11-18)32-23(34)19(27)14-17-8-3-1-4-9-17/h1-6,8-11,19-22,33H,7,12-16,27H2,(H,31,35)(H,32,34)(H4,28,29,30)/t19-,20-,21-,22+/m0/s1 | Synonyms: | PHE-PHE-ARG-chloromethylketone | Definition date: | 2014-04-29 | Last modified: | 2024-09-27 | Release date: | 2014-09-03 | Identifier: | L-phenylalanyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide |
|
| OWF | Name: | (3S)-3-hydroxy-D-asparagine | Formula: | C4 H8 N2 O4 | SMILES: | NC(=O)C(O)C(N)C(O)=O | InChi: | InChI=1S/C4H8N2O4/c5-1(4(9)10)2(7)3(6)8/h1-2,7H,5H2,(H2,6,8)(H,9,10)/t1-,2+/m1/s1 | Definition date: | 2022-05-18 | Last modified: | 2024-09-27 | Release date: | 2023-01-11 | Identifier: | (3S)-3-hydroxy-D-asparagine |
|
| 2Z0 | Name: | N-{[5-(dimethylamino)naphthalen-2-yl]sulfonyl}-L-alpha-glutamyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)
butyl]glycinamide | Formula: | C26 H37 Cl N7 O7 S | SMILES: | ClCC(=O)C(NC(=O)CNC(=O)C(NS(=O)(=O)c2ccc1c(cccc1N(C)C)c2)CCC(=O)O)CCCNC(=[NH2+])N | InChi: | InChI=1S/C26H36ClN7O7S/c1-34(2)21-7-3-5-16-13-17(8-9-18(16)21)42(40,41)33-20(10-11-24(37)38)25(39)31-15-23(36)32-19(22(35)14-27)6-4-12-30-26(28)29/h3,5,7-9,13,19-20,33H,4,6,10-12,14-15H2,1-2H3,(H,31,39)(H,32,36)(H,37,38)(H4,28,29,30)/p+1/t19-,20-/m0/s1 | Synonyms: | dansyl-Glu-Gly-Arg-chloromethyl-ketone | Definition date: | 2008-08-28 | Last modified: | 2024-09-27 | Identifier: | N-{[5-(dimethylamino)naphthalen-2-yl]sulfonyl}-L-alpha-glutamyl-N-[(3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-oxohexan-3-yl]glycinamide |
|
| 2ZC | Name: | O-{[4-(2-aminoethyl)phenyl]sulfonyl}-L-serine | Formula: | C11 H16 N2 O5 S | SMILES: | O=C(O)C(N)COS(=O)(=O)c1ccc(cc1)CCN | InChi: | InChI=1S/C11H16N2O5S/c12-6-5-8-1-3-9(4-2-8)19(16,17)18-7-10(13)11(14)15/h1-4,10H,5-7,12-13H2,(H,14,15)/t10-/m0/s1 | Definition date: | 2014-05-01 | Last modified: | 2024-09-27 | Release date: | 2014-05-14 | Identifier: | O-{[4-(2-aminoethyl)phenyl]sulfonyl}-L-serine |
|
| OWN | Name: | methyl 4-(cyclopropylmethyl)-1-prop-2-enoyl-2,3-dihydroquinoxaline-6-carboxylate | Formula: | C17 H20 N2 O3 | SMILES: | COC(=O)c1ccc2N(CCN(CC3CC3)c2c1)C(=O)C=C | InChi: | InChI=1S/C17H20N2O3/c1-3-16(20)19-9-8-18(11-12-4-5-12)15-10-13(17(21)22-2)6-7-14(15)19/h3,6-7,10,12H,1,4-5,8-9,11H2,2H3 | Definition date: | 2020-04-06 | Last modified: | 2024-09-27 | Release date: | 2020-07-22 | Identifier: | methyl 4-(cyclopropylmethyl)-1-prop-2-enoyl-2,3-dihydroquinoxaline-6-carboxylate |
|
| 2ZF | Name: | N-(tert-butoxycarbonyl)-L-alpha-glutamyl-N-[(1R)-1-(carboxycarbonyl)-3,3-difluoropropyl]-L-leucinamide | Formula: | C21 H33 F2 N3 O9 | SMILES: | O=C(OC(C)(C)C)NC(C(=O)NC(C(=O)NC(C(=O)C(=O)O)CC(F)F)CC(C)C)CCC(=O)O | InChi: | InChI=1S/C21H33F2N3O9/c1-10(2)8-13(18(31)24-12(9-14(22)23)16(29)19(32)33)25-17(30)11(6-7-15(27)28)26-20(34)35-21(3,4)5/h10-14H,6-9H2,1-5H3,(H,24,31)(H,25,30)(H,26,34)(H,27,28)(H,32,33)/t11-,12-,13-/m0/s1 | Definition date: | 2008-12-12 | Last modified: | 2024-09-27 | Identifier: | N-(tert-butoxycarbonyl)-L-alpha-glutamyl-N-[(1R)-1-(carboxycarbonyl)-3,3-difluoropropyl]-L-leucinamide |
|
| 300 | Name: | 2-FORMYL-6-METHOXYPHENYL DIHYDROGEN PHOSPHATE | Formula: | C8 H9 O6 P | SMILES: | O=Cc1cccc(OC)c1OP(=O)(O)O | InChi: | InChI=1S/C8H9O6P/c1-13-7-4-2-3-6(5-9)8(7)14-15(10,11)12/h2-5H,1H3,(H2,10,11,12) | Synonyms: | RU78300 | Definition date: | 2003-06-20 | Last modified: | 2024-09-27 | Identifier: | 2-formyl-6-methoxyphenyl dihydrogen phosphate |
|
| OX6 | Name: | TERT-BUTYL [(1R)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE | Formula: | C11 H19 N3 O3 | SMILES: | O=C(OC(C)(C)C)NC(c1nnco1)C(C)C | InChi: | InChI=1S/C11H19N3O3/c1-7(2)8(9-14-12-6-16-9)13-10(15)17-11(3,4)5/h6-8H,1-5H3,(H,13,15)/t8-/m1/s1 | Definition date: | 2007-05-22 | Last modified: | 2024-09-27 | Identifier: | tert-butyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate |
|
| OX7 | Name: | TERT-BUTYL [(1S)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE | Formula: | C11 H19 N3 O3 | SMILES: | O=C(OC(C)(C)C)NC(c1nnco1)C(C)C | InChi: | InChI=1S/C11H19N3O3/c1-7(2)8(9-14-12-6-16-9)13-10(15)17-11(3,4)5/h6-8H,1-5H3,(H,13,15)/t8-/m0/s1 | Definition date: | 2007-05-22 | Last modified: | 2024-09-27 | Identifier: | tert-butyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate |
|
| 9SJ | Name: | 5-acetamido-2,6-anhydro-3,5,7-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid | Formula: | C11 H18 F N O7 | SMILES: | O=C(C)NC1C(O)C(F)C(OC1CC(CO)O)C(=O)O | InChi: | InChI=1S/C11H18FNO7/c1-4(15)13-8-6(2-5(16)3-14)20-10(11(18)19)7(12)9(8)17/h5-10,14,16-17H,2-3H2,1H3,(H,13,15)(H,18,19)/t5-,6-,7+,8-,9-,10-/m0/s1 | Synonyms: | 5-(acetylamino)-2,6-anhydro-3,5,7-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid | Definition date: | 2017-06-07 | Last modified: | 2024-09-27 | Release date: | 2018-02-21 | Identifier: | 5-(acetylamino)-2,6-anhydro-3,5,7-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid |
|
| 9SL | Name: | [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate | Formula: | C10 H17 N7 O4 | SMILES: | C132C(CCN1C(=NC(COC(=O)N)C2NC(=N3)N)N)(O)O | InChi: | InChI=1S/C10H17N7O4/c11-6-15-5-4(3-21-8(13)18)14-7(12)17-2-1-9(19,20)10(5,17)16-6/h4-5,19-20H,1-3H2,(H2,12,14)(H2,13,18)(H3,11,15,16)/t4-,5-,10-/m0/s1 | Synonyms: | Saxitoxin | Definition date: | 2018-07-18 | Last modified: | 2024-09-27 | Release date: | 2018-08-08 | Identifier: | [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate |
|
| OXD | Name: | OXALIC ACID | Formula: | C2 H2 O4 | SMILES: | O=C(O)C(=O)O | InChi: | InChI=1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6) | Definition date: | 2003-06-20 | Last modified: | 2024-09-27 | Identifier: | ethanedioic acid |
|
| OXE | Name: | ORTHO-XYLENE | Formula: | C8 H10 | SMILES: | c1cccc(c1C)C | InChi: | InChI=1S/C8H10/c1-7-5-3-4-6-8(7)2/h3-6H,1-2H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 1,2-dimethylbenzene |
|
| OXJ | Name: | 1-[3,5-bis(trifluoromethyl)phenyl]-N-methylmethanamine | Formula: | C10 H9 F6 N | SMILES: | CNCc1cc(cc(c1)C(F)(F)F)C(F)(F)F | InChi: | InChI=1S/C10H9F6N/c1-17-5-6-2-7(9(11,12)13)4-8(3-6)10(14,15)16/h2-4,17H,5H2,1H3 | Definition date: | 2019-07-15 | Last modified: | 2024-09-27 | Release date: | 2019-12-11 | Identifier: | 1-[3,5-bis(trifluoromethyl)phenyl]-N-methylmethanamine |
|
| 9SV | Name: | 2-(4-methylpiperazin-1-yl)-3-(phenylsulfanyl)naphthalene-1,4-dione | Formula: | C21 H20 N2 O2 S | SMILES: | C1N(CCN(C1)C2=C(C(c3ccccc3C2=O)=O)Sc4ccccc4)C | InChi: | InChI=1S/C21H20N2O2S/c1-22-11-13-23(14-12-22)18-19(24)16-9-5-6-10-17(16)20(25)21(18)26-15-7-3-2-4-8-15/h2-10H,11-14H2,1H3 | Synonyms: | BOUND FORM | Definition date: | 2017-06-07 | Last modified: | 2024-09-27 | Release date: | 2017-06-21 | Identifier: | 2-(4-methylpiperazin-1-yl)-3-(phenylsulfanyl)naphthalene-1,4-dione |
|
| 9SW | Name: | methoxy-[(3~{R})-3-[(2~{R})-1-methoxy-1,3-bis(oxidanylidene)butan-2-yl]pentadecyl]phosphinic acid | Formula: | C21 H41 O6 P | SMILES: | CCCCCCCCCCCC[CH](CC[P](O)(=O)OC)[CH](C(C)=O)C(=O)OC | InChi: | InChI=1S/C21H41O6P/c1-5-6-7-8-9-10-11-12-13-14-15-19(16-17-28(24,25)27-4)20(18(2)22)21(23)26-3/h19-20H,5-17H2,1-4H3,(H,24,25)/t19-,20+/m1/s1 | Definition date: | 2017-07-09 | Last modified: | 2024-09-27 | Release date: | 2018-01-24 | Identifier: | methoxy-[(3~{R})-3-[(2~{R})-1-methoxy-1,3-bis(oxidanylidene)butan-2-yl]pentadecyl]phosphinic acid |
|
| OXP | Name: | 2-OXO-3-PENTENOIC ACID | Formula: | C5 H6 O3 | SMILES: | O=C(C=C/C)C(=O)O | InChi: | InChI=1S/C5H6O3/c1-2-3-4(6)5(7)8/h2-3H,1H3,(H,7,8)/b3-2- | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3Z)-2-oxopent-3-enoic acid |
|
| 9T1 | Name: | 5-acetamido-2,6-anhydro-3,5,9-trideoxy-3-fluoro-D-erythro-L-gluco-non-4-ulosonic acid | Formula: | C11 H16 F N O7 | SMILES: | O=C(C)NC1C(=O)C(F)C(OC1C(C(C)O)O)C(=O)O | InChi: | InChI=1S/C11H16FNO7/c1-3(14)7(16)10-6(13-4(2)15)8(17)5(12)9(20-10)11(18)19/h3,5-7,9-10,14,16H,1-2H3,(H,13,15)(H,18,19)/t3-,5-,6-,7-,9+,10-/m1/s1 | Synonyms: | 5-(acetylamino)-2,6-anhydro-3,5,9-trideoxy-3-fluoro-D-erythro-L-gluco-non-4-ulosonic acid | Definition date: | 2017-06-07 | Last modified: | 2024-09-27 | Release date: | 2018-02-21 | Identifier: | 5-(acetylamino)-2,6-anhydro-3,5,9-trideoxy-3-fluoro-D-erythro-L-gluco-non-4-ulosonic acid |
|
| OXU | Name: | 2-bromanylethanamine | Formula: | C2 H6 Br N | SMILES: | NCCBr | InChi: | InChI=1S/C2H6BrN/c3-1-2-4/h1-2,4H2 | Definition date: | 2023-08-22 | Last modified: | 2024-09-27 | Release date: | 2023-09-27 | Identifier: | 2-bromanylethanamine |
|
| OXX | Name: | OXALYL-ASPARTYL ANHYDRIDE | Formula: | C6 H6 N O7 | SMILES: | O=C(OC(=O)CC(N)C(=O)O)C([O-])=O | InChi: | InChI=1S/C6H7NO7/c7-2(4(9)10)1-3(8)14-6(13)5(11)12/h2H,1,7H2,(H,9,10)(H,11,12)/p-1/t2-/m0/s1 | Definition date: | 2004-05-20 | Last modified: | 2024-09-27 | Identifier: | {[(3S)-3-amino-3-carboxypropanoyl]oxy}(oxo)acetate (non-preferred name) |
|
| OXY | Name: | OXYGEN MOLECULE | Formula: | O2 | SMILES: | O=O | InChi: | InChI=1S/O2/c1-2 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | molecular oxygen |
|
| 9TG | Name: | 3-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]benzoic acid | Formula: | C15 H16 B N O5 S | SMILES: | c2c(C(=O)O)cc(CC(B(O)O)NC(=O)Cc1cccs1)cc2 | InChi: | InChI=1S/C15H16BNO5S/c18-14(9-12-5-2-6-23-12)17-13(16(21)22)8-10-3-1-4-11(7-10)15(19)20/h1-7,13,21-22H,8-9H2,(H,17,18)(H,19,20)/t13-/m0/s1 | Synonyms: | boronic acid transition state inhibitor EC04 | Definition date: | 2017-06-07 | Last modified: | 2024-09-27 | Release date: | 2017-11-29 | Identifier: | 3-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]benzoic acid |
|
| 9TJ | Name: | 3-{1-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]-1H-1,2,3-triazol-4-yl}benzoic acid | Formula: | C17 H17 B N4 O5 S | SMILES: | C(B(O)O)(Cn2cc(c1cccc(c1)C(O)=O)nn2)NC(=O)Cc3sccc3 | InChi: | InChI=1S/C17H17BN4O5S/c23-16(8-13-5-2-6-28-13)19-15(18(26)27)10-22-9-14(20-21-22)11-3-1-4-12(7-11)17(24)25/h1-7,9,15,26-27H,8,10H2,(H,19,23)(H,24,25)/t15-/m0/s1 | Synonyms: | boronic acid transition state inhibitor S03043 | Definition date: | 2017-06-07 | Last modified: | 2024-09-27 | Release date: | 2017-11-29 | Identifier: | 3-{1-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]-1H-1,2,3-triazol-4-yl}benzoic acid |
|